📊 Score Breakdown
Offering Ability
40
Cash Runway
95
Float Risk
40
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
40%
💰 Capital Raise
55%
• Critical: only 0.4 months cash remaining
📜 Warrant Exercise
35%
• Massive warrant overhang: 301640900% of shares outstanding
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market CapN/A
Shares OutstandingN/A
Float70.15M
Cash$642.0K
Debt$4.54M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest600
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Sep 30, 2024
8-K
8K EVENT
Apr 24, 2026
8-K
8K EVENT
Apr 15, 2026
8-K
8K EVENT
Apr 08, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ZPTAW
📊 ZPTAW FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ZPTAW Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.